User menu

Outcomes of diffuse large B-cell lymphoma patients relapsing after autologous stem cell transplantation: an analysis of patients included in the CORAL study.

Bibliographic reference Van Den Neste, Eric ; Schmitz, N ; Mounier, N ; Gill, D ; Linch, D ; et. al. Outcomes of diffuse large B-cell lymphoma patients relapsing after autologous stem cell transplantation: an analysis of patients included in the CORAL study.. In: Bone Marrow Transplantation, Vol. 52, no.2, p. 216-221 (2016)
Permanent URL http://hdl.handle.net/2078.1/183414
  1. Gisselbrecht Christian, Glass Bertram, Mounier Nicolas, Singh Gill Devinder, Linch David C., Trneny Marek, Bosly Andre, Ketterer Nicolas, Shpilberg Ofer, Hagberg Hans, Ma David, Brière Josette, Moskowitz Craig H., Schmitz Norbert, Salvage Regimens With Autologous Transplantation for Relapsed Large B-Cell Lymphoma in the Rituximab Era, 10.1200/jco.2010.28.1618
  2. Gisselbrecht Christian, Schmitz Norbert, Mounier Nicolas, Singh Gill Devinder, Linch David C., Trneny Marek, Bosly Andre, Milpied Noel J., Radford John, Ketterer Nicolas, Shpilberg Ofer, Dührsen Ulrich, Hagberg Hans, Ma David D., Viardot Andreas, Lowenthal Ray, Brière Josette, Salles Gilles, Moskowitz Craig H., Glass Bertram, Rituximab Maintenance Therapy After Autologous Stem-Cell Transplantation in Patients With Relapsed CD20+Diffuse Large B-Cell Lymphoma: Final Analysis of the Collaborative Trial in Relapsed Aggressive Lymphoma, 10.1200/jco.2012.41.9416
  3. Van Den Neste E, Schmitz N, Mounier N, Gill D, Linch D, Trneny M, Milpied N, Radford J, Ketterer N, Shpilberg O, Dührsen U, Ma D, Brière J, Thieblemont C, Salles G, Moskowitz C H, Glass B, Gisselbrecht C, Outcome of patients with relapsed diffuse large B-cell lymphoma who fail second-line salvage regimens in the International CORAL study, 10.1038/bmt.2015.213
  4. Nagle Sarah J., Woo Kaitlin, Schuster Stephen J., Nasta Sunita D., Stadtmauer Edward, Mick Rosemarie, Svoboda Jakub, Outcomes of patients with relapsed/refractory diffuse large B-cell lymphoma with progression of lymphoma after autologous stem cell transplantation in the rituximab era, 10.1002/ajh.23524
  5. Cheson Bruce D., Horning Sandra J., Coiffier Bertr, Shipp Margaret A., Fisher Richard I., Connors Joseph M., Lister T. Andrew, Vose Julie, Grillo-López Antonio, Hagenbeek Anton, Cabanillas Fernando, Klippensten Donald, Hiddemann Wolfgang, Castellino Ronald, Harris Nancy L., Armitage James O., Carter William, Hoppe Richard, Canellos George P., Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin's Lymphomas, 10.1200/jco.1999.17.4.1244
  6. Thieblemont Catherine, Briere Josette, Mounier Nicolas, Voelker Hans-Ullrich, Cuccuini Wendy, Hirchaud Edouard, Rosenwald Andreas, Jack Andrew, Sundstrom Christer, Cogliatti Sergio, Trougouboff Philippe, Boudova Ludmila, Ysebaert Loic, Soulier Jean, Chevalier Catherine, Bron Dominique, Schmitz Norbert, Gaulard Philippe, Houlgatte Remi, Gisselbrecht Christian, The Germinal Center/Activated B-Cell Subclassification Has a Prognostic Impact for Response to Salvage Therapy in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Bio-CORAL Study, 10.1200/jco.2011.35.4423
  7. Hans C. P., Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray, 10.1182/blood-2003-05-1545
  8. Vose JM, Blood, 80, 2142 (1992)
  9. Robinson S P, Boumendil A, Finel H, Blaise D, Poiré X, Nicolas-Virelizier E, Or R, Malladi R, Corby A, Fornecker L, Caballero D, Pohlreich D, Nagler A, Thieblemont C, Finke J, Bachy E, Vincent L, Schroyens W, Schouten H, Dreger P, Autologous stem cell transplantation for relapsed/refractory diffuse large B-cell lymphoma: efficacy in the rituximab era and comparison to first allogeneic transplants. A report from the EBMT Lymphoma Working Party, 10.1038/bmt.2015.286
  10. Redondo Alba M., Pomares Helena, Vidal María J., Pascual María J., Quereda Belén, Sancho Juan M., Polo Marta, López Javier, Conde Eulogio, Jarque Isidro, Alonso Natalia, Ramírez María J., Fernández Pascual, Sayas María J., Requena María J., Salar Antonio, González José D., González-Barca Eva, Arranz Reyes, Caballero Dolores, Martín Alejandro, Impact of prior rituximab on outcomes of autologous stem-cell transplantation in patients with relapsed or refractory aggressive B-cell lymphoma: a multicentre retrospective Spanish group of lymphoma/autologous bone marrow transplant study, 10.1111/bjh.12676
  11. van Kampen Roel J.W., Canals Carmen, Schouten Harry C., Nagler Arnon, Thomson Kirsty J., Vernant Jean-Paul, Buzyn Agnes, Boogaerts Marc A., Luan Jian-Jian, Maury Sébastien, Milpied Noel J., Jouet Jean-Pierre, Ossenkoppele Gert J., Sureda Anna, Allogeneic Stem-Cell Transplantation As Salvage Therapy for Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma Relapsing After an Autologous Stem-Cell Transplantation: An Analysis of the European Group for Blood and Marrow Transplantation Registry, 10.1200/jco.2010.30.2596
  12. Rigacci Luigi, , Puccini Bendetta, Dodero Anna, Iacopino Pasquale, Castagna Luca, Bramanti Stefania, Ciceri Fabio, Fanin Renato, Rambaldi Alessandro, Falda Michele, Milone Giuseppe, Guidi Stefano, Martelli Massimo Fabrizio, Mazza Patrizio, Oneto Rosi, Bosi Alberto, Allogeneic hematopoietic stem cell transplantation in patients with diffuse large B cell lymphoma relapsed after autologous stem cell transplantation: A GITMO study, 10.1007/s00277-011-1395-9
  13. Sirvent Anne, Dhedin Nathalie, Michallet Mauricette, Mounier Nicolas, Faucher Catherine, Yakoub-Agha Ibrahim, Mohty Mohamad, Robin Marie, Tabrizi Reza, Clement Laurence, Bilger Karin, Larosa Fabrice, Contentin Nathalie, Huyn Anne, François Sylvie, Bulabois Claude-Eric, Ceballos Patrice, Bourrhis Jean-Henri, Buzyn Agnès, Cornillon Jérôme, Guillerm Gaelle, de Revel Thierry, Bay Jacques-Olivier, Guilhot François, Milpied Noël, Low Nonrelapse Mortality and Prolonged Long-Term Survival after Reduced-Intensity Allogeneic Stem Cell Transplantation for Relapsed or Refractory Diffuse Large B Cell Lymphoma: Report of the Société Française de Greffe de Moelle et de Thérapie Cellulaire, 10.1016/j.bbmt.2009.09.002
  14. Bacher U., Klyuchnikov E., Le-Rademacher J., Carreras J., Armand P., Bishop M. R., Bredeson C. N., Cairo M. S., Fenske T. S., Freytes C. O., Gale R. P., Gibson J., Isola L. M., Inwards D. J., Laport G. G., Lazarus H. M., Maziarz R. T., Wiernik P. H., Schouten H. C., Slavin S., Smith S. M., Vose J. M., Waller E. K., Hari P. N., , Conditioning regimens for allotransplants for diffuse large B-cell lymphoma: myeloablative or reduced intensity?, 10.1182/blood-2012-06-436725
  15. Bishop M. R., Dean R. M., Steinberg S. M., Odom J., Pavletic S. Z., Chow C., Pittaluga S., Sportes C., Hardy N. M., Gea-Banacloche J., Kolstad A., Gress R. E., Fowler D. H., Clinical evidence of a graft-versus-lymphoma effect against relapsed diffuse large B-cell lymphoma after allogeneic hematopoietic stem-cell transplantation, 10.1093/annonc/mdn404
  16. Glass Bertram, Hasenkamp Justin, Wulf Gerald, Dreger Peter, Pfreundschuh Michael, Gramatzki Martin, Silling Gerda, Wilhelm Christian, Zeis Matthias, Görlitz Anke, Pfeiffer Sebastian, Hilgers Reinhard, Truemper Lorenz, Schmitz Norbert, Rituximab after lymphoma-directed conditioning and allogeneic stem-cell transplantation for relapsed and refractory aggressive non-Hodgkin lymphoma (DSHNHL R3): an open-label, randomised, phase 2 trial, 10.1016/s1470-2045(14)70161-5
  17. Rezvani A R, Kanate A S, Efron B, Chhabra S, Kohrt H E, Shizuru J A, Laport G G, Miklos D B, Benjamin J E, Johnston L J, Arai S, Weng W-K, Negrin R S, Strober S, Lowsky R, Allogeneic hematopoietic cell transplantation after failed autologous transplant for lymphoma using TLI and anti-thymocyte globulin conditioning, 10.1038/bmt.2015.149
  18. Kim Ji-Won, Kim Sung-Won, Tada Kohei, Fukuda Takahiro, Lee Je-Hwan, Lee Je-Jung, Kwon Ji-Hyun, Bang Soo-Mee, Kim Inho, Yoon Sung-Soo, Lee Jong Seok, Park Seonyang, Allogeneic stem cell transplantation in patients with de novo diffuse large B-cell lymphoma who experienced relapse or progression after autologous stem cell transplantation: a Korea–Japan collaborative study, 10.1007/s00277-014-2045-9
  19. Avivi I, Canals C, Vernant J-P, Wulf G, Nagler A, Hermine O, Petersen E, Yakoub-Agha I, Craddock C, Schattenberg A, Niederwieser D, Thomson K, Blaise D, Attal M, Pfreundschuh M, Passweg J, Russell N, Dreger P, Sureda A, Matched unrelated donor allogeneic transplantation provides comparable long-term outcome to HLA-identical sibling transplantation in relapsed diffuse large B-cell lymphoma, 10.1038/bmt.2014.4
  20. Fenske Timothy S., Ahn Kwang W., Graff Tara M., DiGilio Alyssa, Bashir Qaiser, Kamble Rammurti T., Ayala Ernesto, Bacher Ulrike, Brammer Jonathan E., Cairo Mitchell, Chen Andy, Chen Yi-Bin, Chhabra Saurabh, D'Souza Anita, Farooq Umar, Freytes Cesar, Ganguly Siddhartha, Hertzberg Mark, Inwards David, Jaglowski Samantha, Kharfan-Dabaja Mohamed A., Lazarus Hillard M., Nathan Sunita, Pawarode Attaphol, Perales Miguel-Angel, Reddy Nishitha, Seo Sachiko, Sureda Anna, Smith Sonali M., Hamadani Mehdi, Allogeneic transplantation provides durable remission in a subset of DLBCL patients relapsing after autologous transplantation, 10.1111/bjh.14046
  21. Mondello Patrizia, Younes Anas, Emerging drugs for diffuse large B-cell lymphoma, 10.1586/14737140.2015.1009042
  22. Nowakowski Grzegorz S., Czuczman Myron S., ABC, GCB, and Double-Hit Diffuse Large B-Cell Lymphoma: Does Subtype Make a Difference in Therapy Selection?, 10.14694/edbook_am.2015.35.e449
  23. Camicia Rosalba, Winkler Hans C., Hassa Paul O., Novel drug targets for personalized precision medicine in relapsed/refractory diffuse large B-cell lymphoma: a comprehensive review, 10.1186/s12943-015-0474-2